Kunxian capsule alleviates podocyte injury and proteinuria by inactivating β-catenin in db/db mice
Article in Frontiers in Medicine (June 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Can Kunxian Capsule, a Novel Tripterygium Preparation be Used as an Adjuvant Treatment of Early Recurrent Focal Segmental Glomerular Sclerosis After Renal Transplantation? A Case Report
Article in Transplantation Proceedings (March 2023)
Kunxian capsule alleviates renal damage by inhibiting the JAK1/STAT1 pathway in lupus nephritis
Article in Journal of Ethnopharmacology (March 2023)